期刊文献+

急性脑梗死老龄人群给予超选择性动脉溶栓对比静脉溶栓的临床研究

Clinical study of super selective artery thrombolysis and intravenous thrombolysis in the treatment of elderly patients with acute cerebral infarction
下载PDF
导出
摘要 目的:探讨急性脑梗死老龄人群给予超选择性动脉溶栓对比静脉溶栓的临床效果。方法:研究组实施超选择性动脉溶栓,对照组实施静脉溶栓,比较两组的治疗效果。结果:两组NIHSS评分和BI评分随时间逐渐降低,但组间同时段对比,差异无统计学意义(P>0.05)。研究组总再通率84.09%,显著优于对照组的59.09%。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:急性脑梗死老龄人群给予超选择性动脉溶栓与静脉溶栓治疗其近期和远期疗效均显著,安全性好,但需严格把控时间窗。 Objective:To explore the clinical effect of super selective artery thrombolysis and intravenous thrombolysis in thetreatment of elderly patients with acute cerebral infarction.Methods:The study group was given super selective artery thrombolysis.The control group was given intravenous thrombolysis.We compared the treatment effect of the two groups.Results:The NIHSSscores and BI scores of the two groups were gradually decreased with time,but there was no significant difference between groupsat the same time.In the study group,the total recanalization rate of 84.09% was significantly better than 59.09% of the controlgroup.There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion:The short andlong term effects of super selective artery thrombolysis and intravenous thrombolysis in the treatment of elderly patients with acutecerebral infarction were significant,and the security was good,but we need to strictly control the time window.
作者 孙迎男 杜艳 孙立明 许晗 Sun Yingnan;Du Yan;Sun Liming;Xu Han(Internal Medicine-Neurology,the Second Hospital of General Hospital of Jilin Chemical Group Company 132021)
出处 《中国社区医师》 2016年第18期29-30,共2页 Chinese Community Doctors
关键词 急性脑梗死 超选择性动脉溶栓 静脉溶栓 尿激酶 Acute cerebral infarction Super selective artery thrombolysis Intravenous thrombolysis Urokinase
  • 相关文献

参考文献5

二级参考文献33

  • 1卢宪伟,韦继政,吕小亮,陈伟平.尿激酶颈动脉注射与静脉滴注治疗急性脑梗死的临床疗效对比[J].海南医学,2006,17(3):21-23. 被引量:10
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15727
  • 4Fisher M,Bastan B.Treating acute ischemic stroke[J].Curr Opin Drug Discov Deve1,2008 ; 11(5):626-32.
  • 5张苏明,殷小平.急性脑梗死溶栓治疗的研究进展[M].北京:人民卫生出版社,2003:38.
  • 6Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta analysis of safety data. Stroke, 2003,34 : 2847-2850.
  • 7Nakagawara J, Minematsu K, Okada Y, et al. Thrombolysis with 0. 6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-marketing aheplase registration study(J-MARS). Stroke, 2010,41 : 1984- 1989.
  • 8Bhatia R, Hill MD, Shobha N, et al. Low rates of acute reca- nalization with intravenous recombinant tissue p[asminogen activator in ischemic stroke, real-world experience and a call for action. Stroke,2010,41 : 2254 2258.
  • 9Carpenter CR, Keim SM, Milne WK, et al. Thrombolytic ther- apy for acute isehemic stroke beyond three hours. J Emerg Med,2011,40:82-92.
  • 10Hemmen TM,Rapp KS,Emond JA,et al. Analysis of the Na- tional Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Studies following European coopera- tive acute stroke study HI patient selection criteria. J Stroke Cerebrovasc Dis, 2010,19 : 290-293.

共引文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部